GroupCBT: Effectiveness of Cognitive Behavioral Therapy of Reduction of Test Anxiety

• Sponsor: University Grants Commission (Other)
• Overall Status: Completed
• CT.gov ID: NCT04500340
• Collaborator: (none)
• Enrollment: 80
• Location: 1
• Arms: 2
• Actual Duration (Months): 4.3
• Patients Per Site Per Month: 18.6

Study Details

Study Description

Brief Summary

This study will evaluate the role of Group Cognitive Behavioral Therapy in test anxiety. The study participants will be psychology undergraduates with social work and psychology majors. The students will be selected among those who score three or more in Westside Test Anxiety Scale will participate in the study. Westside Test Anxiety will be used two weeks after completion of the group Cognitive Behavioral Therapy protocol (Flaxman, Bond & Keogh. 2004). The result will be analyzed using the t-test and Cohen's d.

Condition or Disease	Intervention/Treatment	Phase
Test Anxiety	Behavioral: Group CBT for test anxiety	N/A

Study Design

• Study Type: Interventional
• Actual Enrollment: 80 participants
• Allocation: Randomized
• Intervention Model: Parallel Assignment
• Masking: None (Open Label)
• Primary Purpose: Treatment
• Official Title: Test Anxiety: Pervasiveness, Link With Academic Achievement and Impact of Cognitive-behavioral Intervention in Its Reduction
• Actual Study Start Date: Feb 20, 2019
• Actual Primary Completion Date: Jul 1, 2019
• Actual Study Completion Date: Jul 1, 2019

Arms and Interventions

Arm	Intervention/Treatment
Experimental: Group Cognitive Behavioral Therapy (Group CBT) Intervention Group will receive ten-session group CBT for test anxiety. Two sessions will be carried out each week.	Behavioral: Group CBT for test anxiety; The cognitive-behavioral therapy protocol developed by Flaxman, Bond & Keogh (2004) will be used as the intervention protocol. This protocol consists of 10 Sessions which are provided twice a week (each group will have 10 students).
No Intervention: Control Group The Control group will be waiting for the control group who will receive intervention if they demand after final assessment for outcome measure.

Outcome Measures

Primary Outcome Measures

1. Westside Test Anxiety Scale (WTAS) [Change from Baseline Test Anxiety Scores after completion of Group Cognitive Behavioral Therapy ( after one and half month)]

   The WTAS consists of 10 items, each using a Likert response scale where 1= "Never true" and 5= "always true. Total score is divided by 10 to obtain final scores. The total score ranges from one to five. Score of 1-2.9 is considered normal test anxiety and score of 3-5 is labelled as high test anxiety.

Eligibility Criteria

Criteria

• Ages Eligible for Study: N/A and Older
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: Yes

Inclusion Criteria:

• Those Studying Social work and Psychology as Major subjects, Those who have scored 3 and above in Westside Test Anxiety scale

Exclusion Criteria:

• Those scoring below 3 in Westside Test Anxiety Scale

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Nepal Mega College and K and K International College	Kathmandu	Bagmati	Nepal

Sponsors and Collaborators

• University Grants Commission

Investigators

• Principal Investigator: Khem R. Bhatta, Master, Tribhuvan University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Khem Raj Bhatta, Principal Investigator, University Grants Commission
• ClinicalTrials.gov Identifier: NCT04500340
• Other Study ID Numbers: UGrantsCommission
• First Posted: Aug 5, 2020
• Last Update Posted: Aug 5, 2020
• Last Verified: Aug 1, 2020

• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Additional relevant MeSH terms: Anxiety Disorders

Study Results

No Results Posted as of Aug 5, 2020